Education
About Us
Working with TipRanks
Follow Us
Akiko Amakawa Insider Profile
4 Followers
Akiko Amakawa, Corporate Strategy at Takeda Pharmaceutical Co, holds ― shares in Takeda Pharmaceutical Co (Ticker: TKPHF).
Akiko Amakawa Takeda Pharmaceutical Co (TKPHF)Corporate Strategy
Takeda Pharmaceutical Co (TKPHF)
Corporate Strategy
Ranked #54,469 out of 102,596 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-3.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Akiko Amakawa does not currently own shares as a corporate insider.
A breakdown of Akiko Amakawa's holdings
Insider Roles
Corporate Strategy
Roles that Akiko Amakawa holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 10, 2025 - Today
Return:+11.70%
The most profitable trade made by Akiko Amakawa
Akiko Amakawa's Trading History
List of latest transactions for each holding click on a transaction to see Akiko Amakawa's performance on stock
You May Also Like
Akiko Amakawa insider profile FAQ
What is the percentage of profitable transactions made by Akiko Amakawa?
The percentage of profitable transactions made by Akiko Amakawa is 50%.
What is the average return per transaction made by Akiko Amakawa?
The average return per transaction made by Akiko Amakawa is -3.30%.
What stocks does Akiko Amakawa hold?
Akiko Amakawa holds: TKPHF stocks.
What was Akiko Amakawa’s latest transaction?
Akiko Amakawa latest transaction was an Uninformative Buy of ―.
What was Akiko Amakawa's most profitable transaction?
Akiko Amakawa’s most profitable transaction was an Informative Sell of TKPHF stock on July 10, 2025. The return on the trade was 11.70%.
What is Akiko Amakawa's role in Takeda Pharmaceutical Co?
Akiko Amakawa's role in Takeda Pharmaceutical Co is Corporate Strategy.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.